Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Masayuki Miyata is active.

Publication


Featured researches published by Masayuki Miyata.


Ensho | 1990

Influences of heat aggregated human IgG on the proliferation of mononuclear cells

Masayuki Miyata; Satomi Kida; Takashi Kanno; Morihiro Ohara; Reiji Kasukawa

It is believed that circulating immune complexes (IC) play pathogenic roles by affecting lymphocyte and/or monocyte function in type III allergy. We studied the influences of heat aggregated human IgG (AHG), as a model of IC, on the proliferation of mononuclear cells in respect of difference in the involved IgG subclasses. IgG 1 and IgG 2 subclass of AHG (AHG1, AHG 2) suppressed significantly the proliferation of mononuclear cells without mitogens. Proliferation of mononuclear cells stimulated by concanavalin A (Con A) was significantly suppressed not only by AHG 1 and AHG 2 but also by AHG 4. Flow cytometric analysis indicated that unstimulated lymphocytes or monocytes could bind more AHG 1 and AHG 2 than AHG 3 and AHG 4. Since results coincided with the results mentioned above, unstimulated mononuclear cell proliferation was suppressed through the binding of AHG on the surface of mononuclear cells. AHG suppression of mononuclear cells stimulated by Con A was effectively inhibited by an addition of indomethacin and/or catalase.These results indicated that prostaglandin and/or H2O2 might play an important role in inhibition of proliferation of mononuclear cells by AHG. Taken together, IC play a different role in immune network by affecting lymphocytes or monocytes according to difference in IgG subclasses.


Ensho | 1985

Cytotoxicity of synovial lymphocytes of patients with rheumatoid arthritis.

Morihiro Ohhara; Takashi Ohba; Yuki Igari; Chokichi Hashimoto; Yuichiro Kondo; Satoshi Igarashi; Chikara Kobashi; Masayuki Miyata; Hiroshi Yoshida; Reigi Kasukawa; Jun Matsumoto

The lymphocytes in the synovial tissues of patients with rheumatoid arthritis (RA) showed a cytotoxic activity against synovial cultured cells taken from patients with RA, in a similar extent to that of normal peripheral lymphocytes. However, the activity was weaker than that of polymorphonuclear leukocytes in synovial fluids of RA patients. In addition, the synovial lymphocytes of RA patients showed the natural killer activity against K 562 cells which were higher than that of normal peripheral lymphocytes and also ADCC activity which was similar to that of normal peripheral lymphocytes.


Ensho | 1984

Studies on subsets, NK and ADCC activity of lymphocytes in synovial fluids of patients with rheumatoid arthritis

Masayuki Miyata; Hiroyuki Ajima; Yuichiro Kondo; Reiji Kasukawa; Masahiko Ito; Katsumi Chiba

Subsets of lymphocytes in synovial fluids of patients with rheumatoid arthritis (RASF-Ly) along with lymphocytes in peripheral bloods of normal subjects (Healthy-Ly) were studied.Percent of OKT-3+cells (P<0.01), OKT-4+cells (P<0.01), OKT-8+cells (P<0.05) and OK-Ial+cells (P<0.01) of RASF-Ly were significantly higher than those of Healthy-Ly. Therefore, we examined the correlation these percentage of subsets. Positive correlation were observed in RASF-Ly between percentage of OKT-8+cells (P<0.01) or Leu-7+cells (p<0.01) and that of OK-Ial+cells and also between percentage of OKT-8+cells and that of Leu-7+cells of RAST-Ly (p<0.01) . Since OK-Ial represents a marker of activated T cells, both OKT-8+cells and Leu-7+cells in RASF-Ly seemed to be activated and Leu-7+cells seemed also to be immature. NK activity of RASF-Ly was significantly lower than that of Healthy-Ly (p<0.01), whereas ADCC activity of RASF-Ly was similar to that of Healthy-Ly.


Archive | 1995

Drug for prevention and therapy of diseases caused by fibrinoid formation or thrombus formation in the lung and model animals of the diseases

Masayuki Miyata; Reiji Kasukawa; Masanobu Naruto; Nobutaka Ida; Yu-Ichiro Sato; Katsuaki Kojima; Nobuo Ida


Archive | 1995

PREVENTIVE AND REMEDY FOR DISEASES CAUSED BY FIBRINOID OR THROMBUS FORMATION IN THE LUNG

Nobuo Ida; Nobutaka Ida; Reiji Kasukawa; Katsuaki Kojima; Masayuki Miyata; Masanobu Naruto; Yu-Ichiro Sato


Archive | 1996

REMEDY FOR PULMONARY HEART

Reiji Kasukawa; Masayuki Miyata; Yuji Ueno; Hiroshi Koike; Hajimu Kurumatani; Shintaro Nishio


Archive | 1996

Agent for treating cor pulmonale

Reiji Kasukawa; Masayuki Miyata; Yuji Ueno; Hiroshi Koike; Hajimu Kurumatani; Shintaro Nishio


Archive | 1995

Preventive and remedy for diseases caused by fibrinoid or thrombus formation in the lung and model animal for said diseases

Masayuki Miyata; Reiji Kasukawa; Masanobu Naruto; Nobutaka Ida; Yu-Ichiro Sato; Katsuaki Kojima; Nobuo Ida


Fukushima medical journal | 2010

Case of a Young Adult Male Complicated with Ischemic Colitis

Emi Ogata; Takeru Wakatsuki; Hiroaki Sakamoto; Natsumi Sakamoto; Osamu Ito; Kumiko Terashima; Masayuki Miyata; Manabu Tanaka; Hiromasa Ohira


The Fukushima medical journal | 1999

A Case of Primary Biliary Cirrhosis Associated with Polymyositis

Tomohiro Suzuki; Jyunko Takeda; Go Yamamoto; Shoichiro Shishido; Hideo Shishido; Jun Tojo; Hiromasa Ohira; Masayuki Miyata; Katsutoshi Obara; Reiji Kasukawa

Collaboration


Dive into the Masayuki Miyata's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge